Accessibility Menu
Ecs Botanics logo

Ecs Botanics(ASX) ECS

Market CapA$11.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-89%
5 Year-83%
1 Year+0%
1 Month+0%
A$0.01
-14.29%
-0.00Today
Ecs Botanics last closing stock price
MetricPriceDate
Last closeAUD 0.012026-09-08
Ecs Botanics stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%AUD 0.012026-09-01
1 month+0%AUD 0.012026-08-07
3 month+20%AUD 0.012026-06-10
Year to date+0%AUD 0.012025-12-31
1 year+0%AUD 0.012025-09-08
3 year-75%AUD 0.022023-09-08
5 year-82.86%AUD 0.042021-09-09
Since inception-89.23%AUD 0.072019-07-22

Ecs Botanics Financials at a Glance

Market Cap

A$11.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$40.38M

Net Income (TTM)

-A$7.64M

EPS (TTM)

-A$0.00

P/E Ratio

-5.38

Dividend

A$0.00

Beta (Volatility)

0.00 (Low)

Price

A$0.01

Volume

1,623,284

Open

A$0.01

Previous Close

A$0.01

Daily Range

A$0.01 - A$0.01

52-Week Range

A$0.00 - A$0.01

Estimated Earnings Date

Aug 27, 2026

ECS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ecs Botanics

ECS Botanics Holdings Ltd specializes in the cultivation, processing, and commercialization of medicinal cannabis products. The company also markets a variety of hemp-derived wellness and food items, with its primary operations based in Launceston, Australia.

Products and Services
  • Medicinal cannabis cultivation and processing
  • Hemp-derived wellness products
  • Food items featuring hemp ingredients
Growth Outlook
  • Recent revenue of AUD 9.68 million indicates strong market demand
  • Expansion into new product lines expected to drive future growth
  • Strategic partnerships in the agricultural sector may enhance operational capabilities
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 36.5 million
  • Current ratio of 3.45 suggests strong liquidity position
  • Net income for the latest quarter was AUD -1.07 million, reflecting ongoing investment in growth
AI Generated • Sep 5, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Nan-Maree Schoerie

Website

www.ecsbotanics.com.au

Headquarters

Murrabit, VIC 3579, AU

ECS Financials

Key Financial Metrics (TTM)

Gross Margin

0.38%

Operating Margin

-31.63%

Net Income Margin

-9.06%

Return on Equity

-8.21%

Return on Capital

-22.46%

Return on Assets

-6.02%

Earnings Yield

-18.59%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$11.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.60B

Volume

1.62M

Avg. Volume

1.04M

Financials (TTM)

Gross Profit

A$5.71M

Operating Income

-A$13.04M

EBITDA

-A$7.77M

Operating Cash Flow

-A$4.56M

Capital Expenditure

-A$4.59M

Free Cash Flow

-A$9.15M

Cash & ST Invst.

A$1.69M

Total Debt

A$6.88M

Ecs Botanics Performance Analysis

Ecs Botanics annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30AUD 15,388,929190.4%
20242024-06-30AUD 20,030,35630.2%
20252025-06-30AUD 19,363,143-3.3%
20262026-06-30AUD 21,018,3598.5%
Ecs Botanics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-3111.3%
Q42025-06-30-1.1%
Q22025-12-3117.8%
Q42026-06-30-14.7%
Ecs Botanics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30AUD 0.00N/A
20242024-06-30AUD 0.00700.0%
20252025-06-30AUD -0.00N/A
20262026-06-30AUD -0.00-70.5%
Ecs Botanics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-12-31-350.0%
Q42025-06-30-93.3%
Q22025-12-31100.0%
Q42026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

A$9.68M

+10.6%

Gross Profit

A$553.03K

-83.7%

Gross Margin

5.72%

N/A

Market Cap

A$11.21MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$50.94K

N/A

Employees

220

N/A

Net Income

-A$1.07M

-260.6%

EBITDA

-A$3.78M

-399.0%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

A$1.69M

-46.4%

Total Debt

A$6.88M

+572.0%

Accounts Receivable

A$1.89M

+5.9%

Inventory

A$14.76M

+13.7%

Long Term Debt

A$3.34M

+325.0%

Short Term Debt

A$3.54M

+1384.9%

Return on Assets

-6.02%

N/A

Return on Invested Capital

-25.40%

N/A

Free Cash Flow

A$95.96K

+102.8%

Operating Cash Flow

A$152.59K

+108.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICR.AXIntelicare Holdings Limited
A$0.03+0.00%
IXC.AXInvex Therapeutics Ltd
A$0.12+0.00%
TRU.AXTruScreen Group Limited
A$0.01+0.00%
HIQ.AXHITIQ Limited
A$0.01+20.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$105.17+0.10%
NOKNokia
$10.81+0.08%
NVDANvidia
$225.76-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.75+0.07%

Questions About ECS

What is the current price of Ecs Botanics?

Ecs Botanics is trading at A$0.01 per share.

What is the 52-week range for Ecs Botanics?

Over the past 52 weeks, Ecs Botanics has traded between A$0.00 and A$0.01.

How much debt does Ecs Botanics have?

As of the most recent reporting period, Ecs Botanics reported total debt of A$6.88M.

How much cash does Ecs Botanics have on hand?

Ecs Botanics reported A$1.69M in cash and cash equivalents in its most recent financial results.

What is Ecs Botanics’s dividend yield?

Ecs Botanics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services